Attached files
| file | filename |
|---|---|
| EX-23.1 - CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED ACCOUNTING FIRM FOR GEMINI - Gemini Therapeutics, Inc. /DE | ea138289ex23-1_gemini.htm |
| EX-5.1 - OPINION OF GOODWIN PROCTER LLP - Gemini Therapeutics, Inc. /DE | ea138289ex5-1_gemini.htm |
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - Gemini Therapeutics, Inc. /DE | ea138289-s1a1_geminitherap.htm |
Exhibit 23.3
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in the Prospectus constituting a part of this Registration Statement of Gemini Therapeutics Inc. on Amendment No. 1 to Form S-1, of our report dated March 29, 2021, relating to the financial statements of FS Development Corp., which is contained in that Prospectus. We also consent to the reference to us under the caption “Experts” in the Prospectus.
| /s/ WithumSmith+Brown, PC | |
| New York, New York | |
| March 29, 2021 |